An overview of the ergot (Claviceps purpurea) issue in western Canada: challenges and solutions

被引:50
|
作者
Menzies, J. G. [1 ]
Turkington, T. K. [2 ]
机构
[1] Agr & Agri Food Canada, Cereal Res Ctr, Morden, MB R6M 1Y5, Canada
[2] Agr & Agri Food Canada, Lacombe Res Ctr, Lacombe, AB T4L 1W1, Canada
关键词
resistance; disease avoidance; ergot; disease management; wheat; Triticum aestivum; Claviceps purpurea; Triticum turgidum var. durum; pathogen variability; MALE-STERILE WHEAT; DURUM-WHEAT; RESISTANCE; SUSCEPTIBILITY; SCLEROTIA; TEMPERATURE; GERMINATION; STROMATA; DISEASE; BARLEY;
D O I
10.1080/07060661.2014.986527
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Ergot, caused by the ascomycete fungus Claviceps purpurea (Fr.) Tul., has been described to occur since the Middle Ages, but more recently has become a significant issue on the Canadian prairies. In 1999, there was an outbreak of ergot where 12% of all Canadian Western Red Spring (CWRS) and 4% of Canadian Western Amber Durum (CWAD) wheat samples delivered to elevators were infested with ergot sclerotia. A similar outbreak occurred in Manitoba in 2005, followed by outbreaks in 2008 and 2011 in all three Prairie provinces. In 2008, 12-15% of all CWRS samples were infested with ergot, while in 2011, these levels rose to 15-29% of all CWRS samples. In CWAD wheat, 15% of samples were infested in Saskatchewan in 2008 and 14% in 2011. Management practices that may influence ergot severity include crop rotation, management and nutrition, seeding practices, pesticide applications, nature of the crop (i.e. autumn vs. spring crop and self-pollinated vs. cross-pollinated host species), and harvest and postharvest management. Recently, research has been conducted on host resistance and avoidance of infection, although problems in assessing host resistance and variability among pathogen strains have been encountered. Unfortunately, none of these control measures has been found to be entirely successful in controlling ergot on their own. As a consequence, producers should always approach ergot management as an integrated process with strategies that target all components of the disease triangle. Although ergot outbreaks can be sporadic in nature, sustained research funding is necessary to support research that leads to the development of more effective strategies for ergot management.
引用
收藏
页码:40 / 51
页数:12
相关论文
共 50 条
  • [21] Mechanism of alkaloid cyclopeptide synthesis in the ergot fungus Claviceps purpurea
    Walzel, B
    Riederer, B
    Keller, U
    CHEMISTRY & BIOLOGY, 1997, 4 (03): : 223 - 230
  • [22] Fate of ergot (Claviceps purpurea) alkaloids during malting and brewing
    Schwarz, Paul B.
    Hill, Nicholas S.
    Rottinghaus, George E.
    JOURNAL OF THE AMERICAN SOCIETY OF BREWING CHEMISTS, 2007, 65 (01) : 1 - 8
  • [23] Biosynthesis of D-lysergylpeptides in the ergot fungus Claviceps purpurea
    Ortel, I
    Keller, U
    FEBS JOURNAL, 2005, 272 : 559 - 559
  • [25] Proportions of predominant Ergot alkaloids (Claviceps purpurea) detected in Western Canadian grains from 2014 to 2016
    Grusie, T.
    Cowan, V.
    Singh, J.
    McKinnon, J.
    Blakley, B.
    WORLD MYCOTOXIN JOURNAL, 2018, 11 (02) : 259 - 264
  • [26] BIOSYNTHESIS OF ERGOT ALKALOIDS BY PROTOPLASTS OF VARIOUS CLAVICEPS-PURPUREA STRAINS
    MAIER, W
    SCHUMANN, B
    ERGE, D
    GROGER, D
    BIOCHEMIE UND PHYSIOLOGIE DER PFLANZEN, 1980, 175 (8-9): : 815 - 819
  • [27] Control of Ergot (Claviceps purpurea (Fr) Tul.) with New Pesticides
    T. K. Sheshegova
    L. M. Shchekleina
    Russian Agricultural Sciences, 2020, 46 (5) : 472 - 475
  • [28] GLYCOSYLATION OF ERGOT ALKALOIDS BY FREE AND IMMOBILIZED CELLS OF CLAVICEPS-PURPUREA
    KREN, V
    FLIEGER, M
    SAJDL, P
    APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 1990, 32 (06) : 645 - 650
  • [29] The history of ergot of rye (Claviceps purpurea) III: 1940-80
    Lee, M. R.
    JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF EDINBURGH, 2010, 40 (01): : 77 - 80
  • [30] EFFECTS OF 5FLUOROTRYPTOPHAN ON BIOSYNTHESIS OF ERGOT ALKALOIDS BY CLAVICEPS PURPUREA
    SKINNER, WA
    MORRIS, JJ
    STEVENSO.JV
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1967, 56 (03) : 396 - &